The Company announced that it recently met with the U.S. Food and Drug Administration Center for Veterinary Medicine (CVM) regarding the proposed manufacturing transfer of ENTYCE® (capromorelin oral solution).
The Company will host a live conference call on Tuesday, May 9, 2017 at 8:30 a.m. ET to discuss financial results from the first quarter ended March 31, 2017.
The Company announced its fourth quarter and full year 2016 financial results. Aratana will host a live conference call on Tuesday, March 14, 2017 at 8:30 a.m. ET to discuss the results.
The Company plans to present at the Barclays Capital Global Healthcare Conference on Thursday, March 16, 2017 at 9:00 a.m. ET in Miami.